On June 12, 2025, it was reported that one of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck's Gardasil vaccine.
This appointment raises concerns about potential bias and increased scrutiny on Merck's vaccine portfolio, particularly Gardasil. The adviser's past role as an expert witness against the company's product creates a clear conflict of interest.
This development adds to the political and regulatory pressures facing Merck's vaccine business, especially given Kennedy Jr.'s controversial stance on vaccines. Investors are likely to monitor how this influences future policy and public perception.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.